Leon Chen, PhD
InvestorPartner at The Column Group
About
Leon Chen is a founder-turned-VC who led KAI Pharmaceuticals to an Amgen acquisition with approved drug Parsabiv and serves as a hands-on interim executive and board chair for technical platform biotechs.
Invests in
BiotechHealthtech
Colleagues at The Column Group
Aadit Shah
Principal at The Column Group
Arnav Mehta, MD, PhD
Venture Partner at The Column Group
Carla Daniel
Partner at The Column Group
Craig Parker
Venture Partner at The Column Group
Helen Kim
Partner at The Column Group
Hui Tian
Partner at The Column Group
Hui Tian, PhD
Partner at The Column Group
James Evangelista
Partner and CFO at The Column Group
Frequently asked questions
- Who is Leon Chen, PhD?
- Leon Chen is a founder-turned-VC who led KAI Pharmaceuticals to an Amgen acquisition with approved drug Parsabiv and serves as a hands-on interim executive and board chair for technical platform biotechs.
- Where does Leon Chen, PhD work?
- Leon Chen, PhD is Partner at The Column Group.
- What does Leon Chen, PhD invest in?
- Leon Chen, PhD invests in Biotech, Healthtech.